FDA 483 - Vitalant - June 12, 2025

Vitalant, a blood bank in Brisbane, CA, was cited for significant deficiencies in record-keeping, investigation of unexplained discrepancies, and review of records prior to product release. These issues primarily concern the processing and release of irradiated blood products and Frozen Red Blood Cells, indicating systemic failures in maintaining adequate control over critical manufacturing and quality processes.